Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Clofazimine for the Treatment of Pulmonary Mycobacterium Avium Disease

NCT02968212 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT02968212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02968212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Clofazimine for the Treatment of Pulmonary Mycobacterium Avium Disease
Lead sponsor
Oregon Health and Science University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
April 11, 2017
Completion date
October 31, 2026
Enrollment
102 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

mycobacterium avium complex